SITC Publications

Recent biotechnological developments have resulted in increasing interest in immunology biomarkers. These biomarkers have potential clinical utility in the near future as predictors of treatment response. Hence, clinical validation of these predictive markers is critical. The author conclude that clinical validation of immunology biomarkers can be demanding both in terms of time and resources, and careful planning and study design are critical.

Author: Kevin K. Dobbin

Published as a short report in the Journal for ImmunoTherapy of Cancer (2015) 3:40.

#SITCPublication